Skip to main content
Article thumbnail
Location of Repository

The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals

By Fiona MacKenzie, I.M. Gould, Julie Bruce, Jill Mollison, Dominique L. Monnet, Vladimir Krcmery, Barry Cookson and Jos W.M. van der Meer

Abstract

This observational, cross-sectional study describes the role played by clinical microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals. A total of 170 acute care hospitals from 32 European countries returned a questionnaire on antibiotic policies and practices implemented in 2001. Data on antibiotic use, expressed as De.ned Daily Doses per 100 occupied bed-days (DDD/100 BD) were provided by 139 hospitals from 30 countries. A total of 124 hospitals provided both datasets. 121 (71%) of Clinical Microbiology departments and 66 (41%) of Pharmacy departments provided out of hours clinical advice. 70 (41%) of microbiology/infectious disease specialists and 28 (16%) of pharmacists visited wards on a daily basis. The majority of laboratories provided monitoring of blood cultures more than once per day and summary data of antibiotic susceptibility testing (AST) for empiric prescribing (86% and 73% respectively). Most of the key laboratory and pharmacy-led initiatives examined did not vary signi.cantly by geographical location. Hospitals from the North and West of Europe were more likely to examine blood cultures more than once daily compared with other regions (p < 0.01). Hospitals in the North were least likely routinely to report susceptibility results for restricted antibiotics compared to those in the South-East and Central/Eastern Europe (p < 0.01). Hospital wards in the North were more likely to hold antibiotic stocks (100%) compared with hospitals in the South-East which were least likely (39%) (p < 0.001). Conversely, hospital pharmacies in the North were least likely to dispense antibiotics on an individual patient basis (16%) compared with hospital pharmacies from Southern Europe (60%) (p = 0.01). Hospitals that routinely reported susceptibility results for restricted antibiotics had signi.cantly lower median total antibiotic use in 2001 (p < 0.01). Hospitals that provided prescribing advice outside normal working hours had signi.cantly higher antibiotic use compared with institutions that did not provide this service (p = 0.01). A wide range of antibiotic stewardship measures was practised in the participating hospitals in 2001, although there remains great scope for expansion of those overseen by pharmacy departments. Most hospitals had active antibiotic stewardship programmes led by specialists in infection, although there is no evidence that these were associated with reduced antibiotic consumption. There was also no evidence that pharmacy services reduced the amount of antibiotics prescribed.The ARPAC study was funded by the European Commission (project QLK2-CT-2001-00915). F.M. MacKenzie was supported by the European Study Group on Antibiotic Policies to write this manuscript

Topics: Microbiology, Pharmacy, Antibiotic stewardship, Europe
Publisher: Elsevier
Year: 2007
OAI identifier: oai:aura.abdn.ac.uk:2164/191
Journal:

Suggested articles

Citations

  1. A computerassisted management program for antibiotics and other antiinfective agents.
  2. and the ARPAC Steering Group. Antimicrobial susceptibility testing in European hospitals: report from the ARPAC study. doi
  3. Antibiotic exposure as a risk factor for emergence of resistance: the influence of concentration. Symp Ser Soc Appl Microbiol 2002;31: 78S 84S. doi
  4. Antibiotic policies and control of resistance. doi
  5. (1996). Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, doi
  6. (2004). Audits for monitoring the quality of antimicrobial prescriptions. Antibiot Pol Theor Pract
  7. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing.
  8. Clinical impact of rapid identification and susceptibility testing of bacterial blood cultures isolates.
  9. Clinical impact of rapid in vitro susceptibility testing and bacterial identification.
  10. (2004). DC: Population Reference Bureau;
  11. (2005). European Antimicrobial Resistance Surveillance System. EARSS Annual Report doi
  12. Gould IM on behalf of the ARPAC Steering Group. Relationship between the number of different antibiotics used and the total use of antibiotics in European hospitals.
  13. Interpretative reporting and selective antimicrobial susceptibility release in non-critical microbiology results. doi
  14. (2005). Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev doi
  15. (2004). Interventions to optimise antibiotic prescribing in hospitals: The UK approach. Antibiot Pol Theor Pract
  16. (2004). Multidisciplinary antimicrobial management teams and the role of the pharmacist in management of infection. doi
  17. on behalf of the ARPAC Steering Group and the ARPAC Consensus Conference Participants. Report of the consensus conference on antibiotic resistance; prevention and control (ARPAC). doi
  18. (2001). on behalf of the ARPAC Steering Group. Status of infection control policies and organisation doi
  19. (1998). Report from the Invitational EU Conference on the Microbial Threat. Copenhagen, Denmark: Ministry of Health, Ministry of Food, Agriculture and Fisheries;
  20. The impact of laboratory reporting practice on antibiotic utilisation. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.